OLALEKAN AJAYI: Open Payments
NPI 1962087627 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 21 payments from 2 companies in 2025. Trend: 2023 $290 · 2024 $196 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 17 | $211 |
| Tris Pharma Inc | 4 | $74 |
Products named: Qelbree, Onyda XR, Dyanavel XR.
Industry payments across MD — which companies pay providers there.
